Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TytoCare Ltd.

At-home, handheld telehealth device

This article was originally published in Start Up

Executive Summary

TytoCare Ltd.'s Tyto is a telehealth platform and a handheld device with various snap-on attachments to be purchased over the counter to conduct a comprehensive set of physical examinations in the convenience and comfort of one’s own home. The cloud platform allows consumers to perform a self-examination and transmit diagnostic readings to a primary-care physician, as well as conduct an online visit with a remote physician who can also control the device while teleconferencing with the patient.

You may also be interested in...



Building On Successes During Turbulent Times, SR One Closes $600m Fund II

SR One will keep investing in a mix of new companies, early-stage firms and later opportunities with its second fund, raised even as biotech continues to endure challenging financial times.

Vascepa Infringement Dismissal ‘Resulted In Multiple Errors,’ Amarin Argues

Amarin is digging deep to take Hikma back before a US district court in its induced infringement case against the generics manufacturer.

Generic Pylera Leads Charge As Endo Aims To Fix Up Floundering Business

Endo has launched the first generic version of Allergan’s H. pylori treatment Pylera and plans to launch around 10 products from its sterile injectables and generics businesses this year.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT038010

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel